Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.

Fleischmann DF, Unterrainer M, Corradini S, Rottler M, Förster S, la Fougère C, Siepmann T, Schwaiger M, Bartenstein P, Belka C, Albert NL, Niyazi M.

PLoS One. 2019 Jul 24;14(7):e0216111. doi: 10.1371/journal.pone.0216111. eCollection 2019.

2.

Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.

Jaymanne DT, Kaushal S, Chan D, Schembri G, Brazier D, Bailey D, Wheeler H, Back M.

J Med Imaging Radiat Oncol. 2018 Feb;62(1):122-127. doi: 10.1111/1754-9485.12676. Epub 2017 Oct 5.

PMID:
28980392
3.

FET-PET for malignant glioma treatment planning.

Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C.

Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30.

PMID:
21458093
4.

Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.

Rieken S, Habermehl D, Giesel FL, Hoffmann C, Burger U, Rief H, Welzel T, Haberkorn U, Debus J, Combs SE.

Radiother Oncol. 2013 Dec;109(3):487-92. doi: 10.1016/j.radonc.2013.06.043. Epub 2013 Aug 13.

PMID:
23953407
5.

18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M.

J Neurooncol. 2017 Apr;132(2):277-286. doi: 10.1007/s11060-016-2366-8. Epub 2017 Jan 19.

PMID:
28102485
6.

Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.

Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590. doi: 10.1007/s00259-018-4166-1. Epub 2018 Sep 22.

PMID:
30244386
7.

High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.

Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A, Zhang S, Moiseenko V, Benard F, Nichol A.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1100-6. doi: 10.1016/j.ijrobp.2013.09.008. Epub 2013 Oct 22.

PMID:
24161427
8.

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

Weber DC, Zilli T, Buchegger F, Casanova N, Haller G, Rouzaud M, Nouet P, Dipasquale G, Ratib O, Zaidi H, Vees H, Miralbell R.

Radiat Oncol. 2008 Dec 24;3:44. doi: 10.1186/1748-717X-3-44.

9.

Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.

Niyazi M, Landrock S, Elsner A, Manapov F, Hacker M, Belka C, Ganswindt U.

Radiat Oncol. 2013 Jul 12;8:180. doi: 10.1186/1748-717X-8-180.

10.

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).

Oehlke O, Mix M, Graf E, Schimek-Jasch T, Nestle U, Götz I, Schneider-Fuchs S, Weyerbrock A, Mader I, Baumert BG, Short SC, Meyer PT, Weber WA, Grosu AL.

BMC Cancer. 2016 Oct 5;16(1):769.

11.

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.

Piroth MD, Galldiks N, Pinkawa M, Holy R, Stoffels G, Ermert J, Mottaghy FM, Shah NJ, Langen KJ, Eble MJ.

Radiat Oncol. 2016 Jun 24;11:87. doi: 10.1186/s13014-016-0665-z.

12.

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients.

Niyazi M, Jansen NL, Rottler M, Ganswindt U, Belka C.

Radiat Oncol. 2014 Dec 21;9:299. doi: 10.1186/s13014-014-0299-y.

13.

11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.

Hirata T, Kinoshita M, Tamari K, Seo Y, Suzuki O, Wakai N, Achiha T, Umehara T, Arita H, Kagawa N, Kanemura Y, Shimosegawa E, Hashimoto N, Hatazawa J, Kishima H, Teshima T, Ogawa K.

J Neurosurg. 2018 Sep 1:1-11. doi: 10.3171/2018.4.JNS1859. [Epub ahead of print]

PMID:
30239314
14.

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.

Galldiks N, Rapp M, Stoffels G, Fink GR, Shah NJ, Coenen HH, Sabel M, Langen KJ.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):22-33. doi: 10.1007/s00259-012-2251-4. Epub 2012 Sep 29.

PMID:
23053325
15.

Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.

Vees H, Senthamizhchelvan S, Miralbell R, Weber DC, Ratib O, Zaidi H.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):182-93. doi: 10.1007/s00259-008-0943-6. Epub 2008 Sep 26.

PMID:
18818918
16.

Prognostic value of 18F-FET PET imaging in re-irradiation of high-grade glioma: Results of a phase I clinical trial.

Moller S, Law I, Munck Af Rosenschold P, Costa J, Poulsen HS, Engelholm SA, Engelholm S.

Radiother Oncol. 2016 Oct;121(1):132-137. doi: 10.1016/j.radonc.2016.08.014. Epub 2016 Sep 9.

PMID:
27622554
17.

Biological tumour volumes of gliomas in early and standard 20-40 min 18F-FET PET images differ according to IDH mutation status.

Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1242-1249. doi: 10.1007/s00259-018-3969-4. Epub 2018 Feb 27. Erratum in: Eur J Nucl Med Mol Imaging. 2018 Mar 15;:.

PMID:
29487977
18.

The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.

Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1016-23. Epub 2005 Jun 24.

PMID:
15979817
19.

Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.

Harat M, Małkowski B, Makarewicz R.

Radiother Oncol. 2016 Aug;120(2):241-7. doi: 10.1016/j.radonc.2016.06.004. Epub 2016 Jul 1.

PMID:
27378734
20.

Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.

Popp I, Bott S, Mix M, Oehlke O, Schimek-Jasch T, Nieder C, Nestle U, Bock M, Yuh WTC, Meyer PT, Weber WA, Urbach H, Mader I, Grosu AL.

Radiother Oncol. 2019 Jan;130:121-131. doi: 10.1016/j.radonc.2018.08.019. Epub 2018 Sep 12.

PMID:
30219612

Supplemental Content

Support Center